Last edition
News about Market
Asahi Kasei expands its global pharmaceutical footprint with the acquisition of Aicuris, strengthening its pipeline in infectious diseases and advancing treatments for immunocompromised patients.
Market | 21/04/2026 | By News Bureau
Rise in Autoimmune Diseases Reported Across Karnataka, Warn Experts
During Rheumatology Awareness Month, experts highlight increasing cases of autoimmune and rheumatology disorders in Bengaluru and smaller towns, stressing early diagnosis to prevent severe complications and delayed treatment outcomes.
Market | 21/04/2026 | By News Bureau
BioMed X Launches First Research Team in France to Advance AI-Driven Antibody Design
BioMed X launches AI-focused antibody research team in France, aiming to accelerate development of next-generation biologic therapies for cancer and immune diseases.
Market | 21/04/2026 | By News Bureau
Piramal Pharma Solutions Expands ADC Capabilities with Ajinomoto Bio-Pharma Services Pact
Piramal Pharma Solutions partners with Ajinomoto Bio-Pharma Services to accelerate ADC development and manufacturing, enabling access to AJICAP technology.
Market | 20/04/2026 | By News Bureau | 101
Mabwell Signs Malaysia Deal for Denosumab Biosimilars
Mabwell signs a Malaysia licensing deal for denosumab biosimilars, with its partner leading registration and commercialisation while Mabwell handles development, production and supply, strengthening its Asia market expansion strategy.
Market | 20/04/2026 | By News Bureau
Global Study Identifies Most Effective Strategies to Increase Vaccine Uptake
Research in The BMJ finds that expanded access, community engagement, and financial incentives significantly improve vaccination rates across age groups and underserved populations.
Market | 17/04/2026 | By News Bureau
GSK Acquires 100 Percent Equity of 35Pharma for USD 950 Million
GSK completes acquisition of 35Pharma, adding HS235, a potential best-in-class therapy for Pulmonary Hypertension.
Market | 16/04/2026 | By News Bureau
PrecisionLife and Ovation Partner to Launch GLP-1 stratification LDT and GLP-1 DNA Test in H2 2026
PrecisionLife and Ovation partner to launch GLP-1 stratification LDT and consumer DNA test in 2026, with early data showing distinct genetic markers for weight loss and glycemic control.
Market | 16/04/2026 | By News Bureau
MSN Laboratories Launches SEMABEST, India's First Semaglutide After Patent Expiry
MSN Laboratories launches SEMABEST, India’s first semaglutide post patent expiry, priced 50 percent lower than the innovator drug and available as a pre-filled pen for improved patient access.
Market | 15/04/2026 | By News Bureau | 140
Oncodesign Services Expands Collaboration with GIP ARRONAX to Advance Targeted Radiotherapy Research
Oncodesign Services strengthens partnership with GIP ARRONAX to secure access to rare radionuclides like astatine-211, supporting preclinical development of next-generation targeted radiotherapy treatments for cancer and other diseases.
Market | 14/04/2026 | By News Bureau | 119
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy